SI0804465T1 - Novel elastase inhibitors - Google Patents

Novel elastase inhibitors

Info

Publication number
SI0804465T1
SI0804465T1 SI9530682T SI9530682T SI0804465T1 SI 0804465 T1 SI0804465 T1 SI 0804465T1 SI 9530682 T SI9530682 T SI 9530682T SI 9530682 T SI9530682 T SI 9530682T SI 0804465 T1 SI0804465 T1 SI 0804465T1
Authority
SI
Slovenia
Prior art keywords
inhibitors
elastase inhibitors
elastase
compounds
novel elastase
Prior art date
Application number
SI9530682T
Other languages
English (en)
Slovenian (sl)
Inventor
William A. Metz Jr.
Steven L. Gallion
Joseph P. Burkhart
Michael R. Angelastro
Norton P. Peet
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of SI0804465T1 publication Critical patent/SI0804465T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9530682T 1994-06-02 1995-05-05 Novel elastase inhibitors SI0804465T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02
EP95918993A EP0804465B1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors
PCT/US1995/005618 WO1995033763A1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Publications (1)

Publication Number Publication Date
SI0804465T1 true SI0804465T1 (en) 2003-12-31

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530682T SI0804465T1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Country Status (20)

Country Link
EP (1) EP0804465B1 (xx)
JP (1) JP3623799B2 (xx)
KR (1) KR100347285B1 (xx)
CN (1) CN1149877A (xx)
AT (1) ATE246708T1 (xx)
AU (1) AU689589B2 (xx)
CA (1) CA2189527C (xx)
DE (1) DE69531459T2 (xx)
DK (1) DK0804465T3 (xx)
ES (1) ES2199992T3 (xx)
FI (1) FI964781A (xx)
HU (1) HU221197B1 (xx)
IL (1) IL113940A (xx)
NO (1) NO965097L (xx)
NZ (1) NZ285565A (xx)
PT (1) PT804465E (xx)
SI (1) SI0804465T1 (xx)
TW (1) TW403762B (xx)
WO (1) WO1995033763A1 (xx)
ZA (1) ZA954430B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69522940T2 (de) * 1994-06-02 2002-04-04 Merrell Pharma Inc Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
HU221311B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Perfluoroalkyl tripeptides inhibitors of elastase, pharmaceutical compositions comprising thereof and their use
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
PT1654261E (pt) 2003-05-21 2008-01-18 Boehringer Ingelheim Int Compostos inibidores da hepatite c
JP4914355B2 (ja) 2004-07-20 2012-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング C型肝炎インヒビターペプチド類似体
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
WO2007137080A2 (en) 2006-05-23 2007-11-29 Irm Llc Compounds and compositions as channel activating protease inhibitors
CA2677487A1 (en) 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
US20220354833A1 (en) 2019-09-17 2022-11-10 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
IL297211A (en) 2020-04-16 2022-12-01 Mereo Biopharma 4 Ltd Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
JPH06504547A (ja) * 1990-12-28 1994-05-26 ジョージア・テック・リサーチ・コーポレーション ペプチドケトアミド、ケト酸およびケトエステル
ZA926185B (en) * 1991-08-22 1993-03-01 Merrell Dow Pharma Novel orally-active elastase inhibitors.

Also Published As

Publication number Publication date
AU2470995A (en) 1996-01-04
DE69531459D1 (de) 2003-09-11
ES2199992T3 (es) 2004-03-01
CN1149877A (zh) 1997-05-14
CA2189527C (en) 2000-12-19
KR100347285B1 (ko) 2003-01-15
FI964781A0 (fi) 1996-11-29
HUT76926A (hu) 1998-01-28
ZA954430B (en) 1996-02-13
NO965097L (no) 1997-01-31
EP0804465A1 (en) 1997-11-05
NZ285565A (en) 1998-08-26
HU9603312D0 (en) 1997-01-28
PT804465E (pt) 2003-12-31
JPH10500992A (ja) 1998-01-27
DK0804465T3 (da) 2003-11-24
NO965097D0 (no) 1996-11-29
EP0804465B1 (en) 2003-08-06
JP3623799B2 (ja) 2005-02-23
IL113940A (en) 1999-12-31
HU221197B1 (en) 2002-08-28
DE69531459T2 (de) 2004-06-24
ATE246708T1 (de) 2003-08-15
MX9606030A (es) 1998-05-31
CA2189527A1 (en) 1995-12-14
TW403762B (en) 2000-09-01
FI964781A (fi) 1997-01-29
AU689589B2 (en) 1998-04-02
IL113940A0 (en) 1995-08-31
WO1995033763A1 (en) 1995-12-14

Similar Documents

Publication Publication Date Title
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
MX9706069A (es) Nuevos inhibidores de la trombina.
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
GR3034208T3 (en) Human neutrophil elastase inhibitors
CA2189526A1 (en) Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
GB9806632D0 (en) Peptide factor
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
IL113940A0 (en) Novel elastase inhibitors
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
GR3018304T3 (en) Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones.
BR9807883A (pt) Compostos de tetraidropirido
NZ330944A (en) Peptide derivatives
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
TR200003352T2 (tr) Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler
MX9704796A (es) Peptidos novedosos, su preparacion y uso.
PE61999A1 (es) Compuestos de tetrahidropiridina
RU96102532A (ru) Средство для лечения неврологических заболеваний